Defining phenotypes in COPD: an aid to personalized healthcare. (Q38208244)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Defining phenotypes in COPD: an aid to personalized healthcare (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Andrea Segreti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Mario Cazzola

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

1 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

381-388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

Clinical phenotypes of COPD: identification, definition and implications for guidelines

17 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

The overlap syndrome of asthma and COPD: what are its features and how important is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Characteristics of COPD phenotypes classified according to the findings of HRCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Toward a consensus definition for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

COPD exacerbations . 2: aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

The role of bronchodilator treatment in the prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Efficacy of roflumilast in the COPD frequent exacerbator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Azithromycin for prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Distribution of therapeutic response in asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Why does the lung hyperinflate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

No room to breathe: the importance of lung hyperinflation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

The role of long-acting bronchodilators in the management of stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Pulmonary rehabilitation in emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

The clinical features of the overlap between COPD and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Immunology of asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Biomarkers in COPD: time for a deep breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Application of metabolomics approaches to the study of respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

DNA damage due to oxidative stress in Chronic Obstructive Pulmonary Disease (COPD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Association between markers of emphysema and more severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Systemic and airway inflammation and the presence of emphysema in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Targeted treatment in COPD: a multi-system approach for a multi-system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0100-9

A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC).

21 January 2018

1 reference

12 December 2020

Predominant emphysema phenotype in chronic obstructive pulmonary

1 reference

12 December 2020

Comparative effectiveness of drugs for chronic obstructive pulmonary disease

1 reference

12 December 2020

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD

1 reference

12 December 2020

Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients

1 reference

12 December 2020

Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.

1 reference

12 December 2020

Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography

1 reference

12 December 2020

The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop

1 reference

12 December 2020

COPD exacerbations: causes, prevention, and treatment

1 reference

12 December 2020

Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease

1 reference

12 December 2020

The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly

1 reference

12 December 2020

The mitochondrial Italian Human Proteome Project initiative (mt-HPP).

1 reference

12 December 2020

Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation

1 reference

12 December 2020

Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations

1 reference

12 December 2020

10.1007/S40291-014-0100-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 March 2020

1035073260

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24781789%20AND%20SRC:MED&resulttype=core&format=json